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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S291increase in IL1ra. This was especially seen in the M2 macrophages,
indicating that OA SF enhances this phenotype. Surprisingly, RA SF also
seemed to decrease pro-inﬂammatory processes as shown by a
decrease of IL10 and an increase of IL1ra, but also by the decrease of IL6.
In conclusion, SF from diseased joints does not induce pro-inﬂamma-
tory processes, even not when from RA joints. Based on our results, SF
from diseased joints might even induce anti-inﬂammatory processes.
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SYNOVIOCYTE INFLAMMATORY RESPONSES TO CALCIUM
PYROPHOSPHATE DIHYDRATE CRYSTALS INVOLVES CD14 AND TLR-4.
C.R. Scanzello y, A. Nair z, A. Margolis z, K. Mikecz z, A. Finnegan z. yUniv.
of Pennsylvania, Philadelphia, PA, USA; zRush Univ. Med. Ctr., Chicago, IL,
USA
Purpose: Low-grade synovial inﬂammation is seen in the setting of
osteoarthritis (OA), even in early-stages, although the molecular trig-
gers of inﬂammation in OA are as yet unclear. Stimulation of Toll-like
receptors (TLRs) by endogenous molecules released during cartilage
matrix damage and chondrocyte stress is hypothesized to be one
mechanism leading to synovial inﬂammation in OA. We previously
reported that a TLR co-receptor, soluble CD14 (sCD14), is found in
synovial ﬂuid (SF) from patients with early and advanced stage OA, and
can augment responses of ﬁbroblast-like synoviocytes (FLS) to typical
TLR-2 and TLR-4 ligands. The purpose of the current study was to
determine if sCD14 can impact FLS responses to crystalline ligands
(speciﬁcally MSU and CPPD) that have relevance to OA pathogenesis.
Methods: Synovial tissue specimens for establishment of FLS lines were
obtained from asymptomatic organ donors with no documented his-
tory of joint disease via IRB approved protocols. Recombinant human
CD14 (0.5 ug /ml, based on concentrations found in patient SF) in
combination with MSU crystals or CCPD crystals (both from Invivogen)
used in concentrations from 0.05 to 50 ug/ml were used to stimulate
primary FLS at passage 4. Stimulationwas measured by IL-8 release into
the culture media measured by ELISA (Invitrogen). Responses of HEK-
293 cell lines transfected with TLR-2 or TLR-4 were measured to
determine the dependence of observed responses on these receptors. A
peptide inhibitor of TLR-4 signaling (CLI-095, Invivogen) was used to
test whether FLS responses were related to TLR-4 mediated mediated
signaling.
Results: CPPD, but not MSU, was able to stimulate IL-8 production from
FLS cells in the presence of CD14. Experiments in three separate cell
lines demonstrated that addition of CD14 augmented the effect of CPPD
down to a concentration of 0.5 ug/ml (repeated measures ANOVA, p ¼
0.02 at 0.5 ug/ml, with CD14 vs. without CD14). CPPD, in combination
with rhCD14, was able to stimulate HEK-293 cells transfected with TLR-
4, but not TLR-2. In FLS cells, addition of the TLR-4 inhibitor CLI-095
prevented the response to CD14þCPPD.
Conclusions: CPPD crystals stimulate FLS production of IL-8 in the
presence of CD14. Our experiments indicate that TLR-4 is involved in
this response. As CPPD crystals are known to be common in the joint
tissues and ﬂuid of patients affected by OA, it is possible that the
synovial response to these crystals may contribute to inﬂammation in
OA.
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ANTI-INFLAMMATORY EFFECTS OF LANSOPRAZOLE BY INHIBITING
NITRIC OXIDE PRODUCTION VIA REACTIVE OXYGEN SPECIES IN
MURINE MACROPHAGE RAW 264.7 CELLS
S. Ichimaru, S. Nakagawa, Y. Arai, S. Tsuchida, H. Inoue, T. Matsuki,
D. Taniguchi, R. Oda, H. Fujiwara, T. Kubo. Kyoto Prefectural Univ. of Med.,
Kyoto, Japan
Purpose: Lansoprazole (LPZ), proton pump inhibitor, is widely used
clinically to treat gastrointestinal mucosal disorders. The mucosal-
protective effects of PPIs are due primarily to their inhibition of P-
ATPase. More recently, however, PPIs were shown to have local
pleiotropic effects in the gastric mucosa, including having anti-
apoptotic effects, inhibiting the generation of reactive oxygen species
(ROS), and inhibiting the expression of macrophage adhesion mole-
cules. Aberrantly activated macrophages overproduce inﬂammatorymediators such as nitric oxide (NO) and prostaglandin E2 (PGE2),
both of which are involved in the pathogenesis of many inﬂamma-
tory diseases including rheumatoid arthritis. Agents that target
macrophages, inhibiting the secretion of multiple inﬂammatory
mediators, may provide a breakthrough as novel therapy for patients
with inﬂammatory disorders. The purpose of this study is to inves-
tigate the effects of LPZ on activated macrophages and the mecha-
nisms by which LPZ inhibits the production of inﬂammatory
mediators such as NO and PGE2.
Methods: RAW264.7 murine macrophages were used in this study. The
cells were incubated with various concentrations of LPZ for 24 h and the
cell viability was evaluated by MTS assay. The cells were treated with
various concentrations of LPZ in the presence or absence of lip-
opolysaccharide (LPS), and the concentration of NO and PGE2 in
supernatant was measured. iNOS and COX-2 expression were analysed
by Western blotting. We used RT-PCR to determine whether P-ATPase
mRNA is expressed in RAW264.7 cells. We measured intracellular ROS
concentrations of LPS-stimulated cells by ﬂow cytometry in the pres-
ence or absence of 100mM LPZ. To determine whether LPS-induced ROS
affects NO and PGE2 production, we measured NO and PGE2 levels after
controlling ROS levels using antioxidants such as N-acetyl-L-cysteine
(NAC), an ROS scavenger, and Diphenylene iodonium (DPI), an inhibitor
of NADPH oxidase.
Results: LPZ, at concentrations of 0–100 mM, had no effects on the
viability of RAW264.7 cells. LPZ inhibited the LPS-induced production of
NO and PGE2 in a concentration-dependent manner. The expression of
iNOS and COX-2 was also suppressed by LPZ at a concentration of 100
mM. P-ATPase expressed in mouse gastric mucosal tissue but not in
RAW264.7 cells. In addition, LPZ alone did not alter ROS levels in the
absence of LPS, whereas preincubationwith LPZ prior to LPS stimulation
signiﬁcantly reduced the levels of ROS. NAC had no effect on NO levels
and, DPI, an inhibitor of NADPH oxidase, decreased NO levels, but nei-
ther NAC nor DPI altered PGE2 levels.
Conclusions: We found that LPZ not only inhibited NO and PGE2
production but also suppressed iNOS and COX-2 expression. This
result suggests that LPZ exerts anti-inﬂammatory effects by sup-
pressing the expression of iNOS and COX-2. We found that LPS
stimulation increased the production of both ROS and NO and that
DPI suppresses LPS-induced NO production. These ﬁndings suggest
that, LPS stimulation increases ROS production and is associated
with inﬂammatory responses by inducing NO production. NAC did
not inhibit LPS-induced NO production, indicating that once ROS has
been produced, it is difﬁcult to control NO production. Our ﬁndings,
showing that LPZ suppressed the inﬂammatory activity of activated
macrophages in vitro, suggest that LPZ may be promising in the
treatment of inﬂammatory diseases involving activated macrophages
including rheumatoid arthritis. Studies in animal models may show
these therapeutic effects.
